The oral demonstration.

The oral demonstration, combined with the four poster presentations, on non-clinical pharmacology, scientific pharmacokinetics/pharmacodynamics and a U.S. Phase 2a scholarly study, marks Astellas’ first appearance at the ADA meeting and demonstrates the company’s commitment to find remedies for diabetes. Related StoriesStudy finds high prevalence of dehydration in the elderly living in UK care homesBariatric surgery improves weight, metabolic health and quality of life in adolescents after 3 yearsStudy explores diabetes screening for patients with severe mental illnessDuring the display , entitled ASP1941, a Novel, Selective SGLT2 Inhibitor, Was Effective and safe in Japanese Healthy Volunteers and Individuals with Type 2 Diabetes Mellitus, Dr. Atsunori Kashiwagi from Shiga University of Medical Technology presented data from a 12-week dosage finding study in 361 Japanese patients with Type 2 diabetes mellitus.2011: 7-14. Deltour, I., C. Johansen, A. Auvien, et al. Time Trends in Human brain Tumor Incidence Prices in Denmark, Finland, Norway, and Sweden, 1974-2003. J. Nat. Malignancy Inst. 101.24 : 1721-1724. Huff, J. Stephen. Human brain Neoplasms. Apr. 8, 2013. Korley, F., J. Pham, T. Kirsch, et al. Usage of Advanced Radiology During Appointments to U.S. Crisis Departments for Injury-Related Circumstances, 1998-2007. JAMA 304.13 : 1465-1471. The online insurance marketplaces are likely to begin signing people up in October 2013 for policies that begin in January 2014.

Other entries from category "laboratory":

Random entries